Your browser doesn't support javascript.
loading
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz, Raphael J; Li, Sue; Grinsztejn, Beatriz; Dawood, Halima; Liu, Albert Y; Magnus, Manya; Hosseinipour, Mina C; Panchia, Ravindre; Cottle, Leslie; Chau, Gordon; Richardson, Paul; Marzinke, Mark A; Hendrix, Craig W; Eshleman, Susan H; Zhang, Yinfeng; Tolley, Elizabeth; Sugarman, Jeremy; Kofron, Ryan; Adeyeye, Adeola; Burns, David; Rinehart, Alex R; Margolis, David; Spreen, William R; Cohen, Myron S; McCauley, Marybeth; Eron, Joseph J.
Affiliation
  • Landovitz RJ; UCLA Center for Clinical AIDS Research and Education, Los Angeles, California, United States of America.
  • Li S; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Dawood H; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu Natal, Durban, South Africa.
  • Liu AY; Bridge HIV, Population Health Division, San Francisco Department of Health, San Francisco, California, United States of America.
  • Magnus M; Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, United States of America.
  • Hosseinipour MC; UNC Project-Malawi, Lilongwe, Malawi.
  • Panchia R; Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa.
  • Cottle L; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Chau G; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Richardson P; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Marzinke MA; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Hendrix CW; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Eshleman SH; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Zhang Y; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Tolley E; FHI360, Durham, North Carolina, United States of America.
  • Sugarman J; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Kofron R; Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Adeyeye A; UCLA Center for Clinical AIDS Research and Education, Los Angeles, California, United States of America.
  • Burns D; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Rinehart AR; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Margolis D; ViiV Healthcare, Durham, North Carolina, United States of America.
  • Spreen WR; ViiV Healthcare, Durham, North Carolina, United States of America.
  • Cohen MS; ViiV Healthcare, Durham, North Carolina, United States of America.
  • McCauley M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Eron JJ; FHI360, Durham, North Carolina, United States of America.
PLoS Med ; 15(11): e1002690, 2018 11.
Article in En | MEDLINE | ID: mdl-30408115

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / Anti-HIV Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Brasil Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / HIV Infections / Anti-HIV Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / America do sul / Brasil Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2018 Document type: Article Affiliation country: Country of publication: